Latest Content

Tracy Milgram-Posner sat down for an interview with CURE to discuss BRCAStrong and the impact she hopes to make for anyone with breast cancer.

A breast cancer survivor and mother discusses the importance of prioritizing her own needs.

Dr. Joshua Sabari, Dr. Petros Grivas, and Dr. Chandler Park discuss new developments in perioperative therapy for muscle-invasive bladder cancer.

Dr. Minetta Liu explains how Signatera detects tumor DNA after bladder surgery, guiding treatment and identifying patients who need immunotherapy.

During my cancer journey, anticipatory anxiety made me ask “what if” questions, but reframing them with hope helped me stay positive and improve my chances of surviving.

Dr. Suneel Kamath sat down for Pancreatic Cancer Awareness Month to discuss advances in treatment and the importance of raising awareness for this disease.

MB-105 received a special FDA status to help deliver faster treatment options for people with relapsed T-cell lymphoma who have few options.

Four-time non-Hodgkin lymphoma survivor Shell Rowe knows very well about the importance of finding the lighthearted side of an otherwise serious situation.

While cancer patients can experience ghosting, and cancer ghosting is real, it is possible to revisit relationships to avoid putting blaming the person who appears to be slipping away.

Experts highlight perioperative Padcev plus Keytruda in bladder cancer, showing potential practice-changing results from ESMO 2025 for patients.

I’ve learned that social media can unite people at hereditary cancer risk but often leaves diverse voices out, so real change means every story is seen and valued.

The artwork of Gail Durant, winner of the annual CURE Calendar Contest, captured the heart of her family’s connection to home and the cancer journey.

For some with GIST, bezuclastinib plus Sutent led to longer progression-free survival and higher response rates compared with Sutent alone.